journal article·2021-07

Role of Na+, K+-ATPase ion pump in osteoinduction

Zhurong Tang, Siyu Chen, Yilu Ni, Rui Zhao, Xiangdong Zhu, Xiao Yang, Xingdong Zhang

Acta Biomaterialia· Volume 129
Publisher page

Abstract

Porous biphasic calcium phosphate bioceramic (BCP) possesses osteoinductivity to induce the osteoblastic commitment of mesenchymal stem cells (MSCs) and ectopic bone formation. However, the underlying mechanism remains enigmatic. We performed a gene array analysis of MSCs cocultured with BCP to screen for candidate osteoinductive modulators. Na+, K+-ATPase (NKA), an ion transporter, therefore was identified as a crucial ion transporter in regulating the osteogenesis of the cells. NKA activator, a polyclonal antibody, enriched the cytomembrane abundance of NKA and lead to an enhanced osteogenic effect of BCP. As indicated in gene array analysis and suggested by co-immunoprecipitation assay, protein phosphatase 2A (PP2A) was elevated by BCP to dephosphorylate NKA and prevent its endocytosis. The inhibition of NKA by ouabain resulted in an adverse effect on osteoinductivity of BCP. We further altered NKA activity in mice implanted with BCP and found that the intensity and incidence of osteoinduction was increased by the NKA activator. We went one step further by investigating the potential of targeting NKA in osteoporotic bone regeneration. Activating NKA upregulated osteogenic gene expression and calcium deposition ability of osteoporotic osteoblasts. Furthermore, activation of NKA in mice ameliorated estrogen-deficiency induced bone loss, in terms of increased bone mass and improved bending strength. With this osteoinductive bioceramic derived ion transporter target, we demonstrate that the activation of NKA has significant potential to revolutionize the regeneration of bone. STATEMENT OF SIGNIFICANCE: In this study, we identified an important role of Na+, K+-ATPase (NKA) have played in osteoinductivity of biphasic calcium phosphate bioceramic (BCP). Furthermore, we demonstrated the therapeutic potential of targeting NKA in osteoporotic bone regeneration. Numerous gene and protein targets to treat osteoporosis were discovered every year, mainly obtained by genomic and proteomic screenings of a large population. In contrast, our study identified an unrevealed bone regenerating target from the upregulated genes induced by an osteoinductive biomaterial. The approach was cost-saving since it did not require a large sample pool. Furthermore, the target derived from this approach was proven to be anabolic. Identification of an anabolic agent holds significant value since most of the current anti-osteoporotic therapies are antiresorptive.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Metabolism and Diseases · Bone health and treatments · Parathyroid Disorders and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (77)

Show source-provided references
1. Tenogenic differentiation of human MSCs induced by the topography of electrochemically aligned collagen threads10.1016/j.biomaterials.2011.11.066 ↗
2. The use of carbon nanotubes to induce osteogenic differentiation of human adipose-derived MSCs invitro and ectopic bone formation invivo10.1016/j.biomaterials.2012.03.045 ↗
3. Stem cell homing-based tissue engineering using bioactive materials10.1007/s11706-017-0373-0 ↗
4. Calcium phosphate surfaces promote osteogenic differentiation of mesenchymal stem cells10.1111/j.1582-4934.2007.00103.x ↗
5. Effect of calcium phosphate ceramic substrate geometry on mesenchymal stromal cell organization and osteogenic differentiation10.1088/1758-5090/8/2/025006 ↗
6. Hydroxyapatite nanobelt/polylactic acid Janus membrane with osteoinduction/barrier dual functions for precise bone defect repair10.1016/j.actbio.2018.02.033 ↗
7. Sintered porous hydroxyapatites with intrinsic osteoinductive activity: geometric induction of bone formation
8. Heterotopic bone formation around porous hydroxyapatite ceramics in the subcutis of dogs
9. Zhang · 1991 · 408
10. Relevance of osteoinductive biomaterials in critical-sized orthotopic defect10.1002/jor.20115 ↗
11. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting10.1073/pnas.1003600107 ↗
12. Molecular mechanisms of biomaterial-driven osteogenic differentiation in human mesenchymal stromal cells10.1039/c3ib40027a ↗
13. Comparison of ectopic bone formation process induced by four calcium phosphate ceramics in mice10.1016/j.msec.2016.06.097 ↗
14. Bone morphogenetic protein Smads signaling in mesenchymal stem cells affected by osteoinductive calcium phosphate ceramics10.1002/jbm.a.35242 ↗
15. Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers10.1016/j.biomaterials.2012.01.015 ↗
16. Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling10.1073/pnas.1321717111 ↗
17. Bone morphogenetic protein-2, -6, and -7 differently regulate osteogenic differentiation of human periodontal ligament stem cells10.1002/jbm.b.32988 ↗
18. Bone morphogenetic proteins: a powerful osteoinductive compound with non-negligible side effects and limitations10.1002/biof.1177 ↗
19. Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures10.1007/s11999-012-2684-x ↗
20. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion10.1097/01.brs.0000201424.27509.72 ↗
21. Assessment of Gene Regulation by Bone Morphogenetic Protein 2 in Human Marrow Stromal Cells Using Gene Array Technology10.1359/jbmr.2001.16.12.2192 ↗
22. New insights into the regulation of Na+,K+-ATPase by ouabain
23. Identification of a Mutant α1 Na/K-ATPase That Pumps but Is Defective in Signal Transduction10.1074/jbc.M113.467381 ↗
24. Activation of (Na+ + K+)-ATPase modulates cardiac L-type Ca2+ channel function10.1124/mol.108.052597 ↗
25. Activation of (Na+ + K+)-ATPase induces positive inotropy in intact mouse heart in vivo10.1016/j.bbrc.2006.08.070 ↗
26. Mechanistic Distinction Between Activation and Inhibition of (Na++K+)-ATPase-Mediated Ca2+ Influx In Cardiomyocyte10.1016/j.bbrc.2011.02.013 ↗
27. Cardioprotection induced by Na(+)/K(+)-ATPase activation involves extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt pathway10.1093/cvr/cvq263 ↗
28. Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study10.1007/s00198-006-0250-7 ↗
29. Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes10.1007/s00198-015-3040-2 ↗
30. C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y10.1007/BF00403963 ↗
31. ATPase pumps in osteoclasts and osteoblasts10.1016/S1357-2725(01)00142-X ↗
32. The Calcium Pumping ATPase of the Plasma Membrane10.1146/annurev.ph.53.030191.002531 ↗
33. Expression of sodium-dependent phosphate (NadPi) transport in Xenopus laevis oocytes induced by mRNA from 1 alpha, 25-dihydroxyvitamin D3-treated rat osteoblast-like cells10.1007/BF00373840 ↗
34. Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling10.1007/s00774-013-0493-2 ↗
35. Effect of phase composition on protein adsorption and osteoinduction of porous calcium phosphate ceramics in mice
36. Administration duration influences the effects of low-magnitude, high-frequency vibration on ovariectomized rat bone10.1002/jor.23128 ↗
37. Selective effect of hydroxyapatite nanoparticles on osteoporotic and healthy bone formation correlates with intracellular calcium homeostasis regulation10.1016/j.actbio.2017.07.009 ↗
38. Purification of the Sodium- and Potassium-dependent Adenosine Triphosphatase from Canine Renal Medulla10.1016/S0021-9258(18)62067-8 ↗
39. Na,K-ATPase alpha1-subunit dephosphorylation by protein phosphatase 2A is necessary for its recruitment to the plasma membrane10.1096/fj.06-6503fje ↗
40. Activation of (Na+ + K+)-ATPase10.1016/j.bbrc.2005.10.067 ↗
41. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography10.1002/jbmr.141 ↗
42. Bone mineral density, microarchitectural and mechanical alterations of osteoporotic rat bone under long-term whole-body vibration therapy10.1016/j.jmbbm.2015.08.040 ↗
43. Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study10.1016/j.bone.2011.02.007 ↗
44. Positive alterations of viscoelastic and geometric properties in ovariectomized rat femurs with concurrent administration of ibandronate and PTH10.1016/j.bone.2012.09.039 ↗
45. Immunization with Na+/K+ ATPase DR peptide prevents bone loss in an ovariectomized rat osteoporosis model10.1016/j.bcp.2018.08.024 ↗
46. Healing of osteoporotic bone defects by micro-/nano-structured calcium phosphate bioceramics10.1039/C8NR09417A ↗
47. Administration of PTH and ibandronate increases ovariectomized rat compact bone viscoelasticity10.1016/j.jmbbm.2013.03.009 ↗
48. Function of FXYD Proteins, Regulators of Na, K-ATPase10.1007/s10863-005-9476-x ↗
49. Molecular mechanisms of Na/K-ATPase-mediated signal transduction10.1111/j.1749-6632.2003.tb07234.x ↗
50. Postnatal changes in Na,K-ATPase isoform expression in rat cardiac ventricle. Conservation of biphasic ouabain affinity10.1016/S0021-9258(18)31589-8 ↗
51. Roles of calcium phosphate-mediated integrin expression and MAPK signaling pathways in the osteoblastic differentiation of mesenchymal stem cells10.1039/C6TB00349D ↗
52. Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms10.22203/eCM.v021a31 ↗
53. A proposed mechanism for material-induced heterotopic ossification10.1016/j.mattod.2018.10.036 ↗
54. Osteoinduction of porous bioactive titanium metal10.1016/S0142-9612(03)00551-9 ↗
55. Osteoinduction of porous Ti implants with a channel structure fabricated by selective laser melting10.1016/j.actbio.2011.01.037 ↗
56. Bio-surface coated titanium scaffolds with cancellous bone-like biomimetic structure for enhanced bone tissue regeneration10.1016/j.actbio.2020.07.024 ↗
57. Contraction of single vascular smooth muscle cells by phenylephrine at constant [Ca2+]i
58. Protein kinase C - a question of specificity10.1016/0968-0004(94)90038-8 ↗
59. Calcium/calmodulin signaling controls osteoblast growth and differentiation10.1002/jcb.20675 ↗
60. The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation10.1073/pnas.1208916109 ↗
61. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation10.1038/nm1514 ↗
62. Cytotoxicity of vacuolar H(+)-ATPase inhibitors to UMR-106 rat osteoblasts: an effect on iron uptake into cells?10.1006/cbir.1994.1060 ↗
63. Role of estrogen and progesterone in the modulation of CNG-A1 and Na/K+-ATPase expression in the renal cortex10.1159/000339055 ↗
64. Estradiol-induced expression of N(+)-K(+)-ATPase catalytic isoforms in rat arteries: gender differences in activity mediated by nitric oxide donors10.1152/ajpheart.00990.2003 ↗
65. Progesterone regulation of Na/K-ATPase β1 subunit expression in the mouse uterus during the peri-implantation period10.1016/j.theriogenology.2013.02.018 ↗
66. Interference between insulin and estradiol signaling pathways in the regulation of cardiac eNOS and Na(+)/K(+)-ATPase10.1016/j.ejphar.2011.01.016 ↗
67. N-myc Downstream-regulated Gene 2, a Novel Estrogen-targeted Gene, Is Involved in the Regulation of Na+/K+-ATPase10.1074/jbc.M111.247825 ↗
68. Effect of L-lysine and L-arginine on primary osteoblast cultures from normal and osteopenic rats10.1016/S0753-3322(01)00054-3 ↗
69. Early cell adhesion events differ between osteoporotic and non-osteoporotic osteoblasts10.1016/S0736-0266(01)00045-6 ↗
70. Drugs targeting SIRT1, a new generation of therapeutics for osteoporosis and other bone related disorders?10.1016/j.phrs.2019.03.007 ↗
71. Models and screening assays for drug discovery in osteoporosis10.1517/17460441.2010.532484 ↗
72. Using GWAS to identify novel therapeutic targets for osteoporosis10.1016/j.trsl.2016.10.009 ↗
73. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation10.1016/j.jdent.2019.01.015 ↗
74. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss10.1038/s41467-017-02490-4 ↗
75. Participation of Na,K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na,K-ATPase alpha subunits10.1021/bi001073y ↗
76. Critical role of the α1-Na(+), K(+)-ATPase subunit in insensitivity of rodent cells to cytotoxic action of ouabain10.1007/s10495-015-1144-y ↗
77. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate10.1006/abbi.1994.1136 ↗